For the first time, this research aims to prepare a new photoluminescence and porous bio-nanocomposite of the starch nanoparticles@metal-organic framework (Manganese-Zinc) (PSt NPs@MOF(Mn-Zn)) through the composition of starch nanoparticles (St NPs), carbon dots (CDs), and MOF(Mn-Zn) in three steps. The findings of performed characterization techniques approved the success in the fabrication of the PSt NPs@MOF(Mn-Zn). In the following, the potential of PSt NPs@MOF(Mn-Zn) was evaluated as a drug carrier for co-delivery of doxorubicin (DOX) and 5-fluorouracil (5-Fu) and ((5-Fu+DOX)@PSt NPs@MOF(Mn-Zn)) was obtained. Brunauer-Emmett-Teller (BET) test showed that the surface area and total pore volume of 275.98 m2 g-1 and 0.4885 cm3 g-1 for PSt NPs@MOF(Mn-Zn) were reduced to 3.8535 m2 g-1 and 0.0029023 cm3 g-1 for (5-Fu+DOX)@PSt NPs@MOF(Mn-Zn) that is a good indication of the loading of studied drug molecules in the prepared system. Moreover, the higher release rate of DOX and 5-Fu at pH 5.0 than pH 7.4 is one of the main signs of the system's suitability in cancer treatment. The observation of HeLa cell viability up to 70% after treatment with PSt NPs@MOF(Mn-Zn) approved its biocompatibility and its potential for use as a drug carrier. Overall it can be concluded that the PSt NPs@MOF(Mn-Zn) has the criteria to be proposed as a new bio-nanocomposite for controlled DOX and 5-Fu delivery.